Supplements8 min read
Resistant starch and weight loss: what human trials actually show
A positive human trial adds promise, but starch type, diet, metabolic outcomes, and long-term weight control still need separate scrutiny.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Supplements9 min read
Vitamin C and colds: prevention, shorter illness and treatment
Vitamin C research depends on when supplementation starts and what it measures. Understand modest duration findings and the limits of treatment claims.
Read article
TRT9 min read
Alex Tatem’s TRT Treatment Spectrum: The Evidence Behind Choosing a Route
Gels, injections, capsules and pellets make different demands on daily life. Product labels and clinical evidence help separate practical fit from claims of superiority.
Read article
Peptides9 min read
Selank versus benzodiazepines: what the human comparisons actually show
Small comparative studies exist, but they do not establish class-wide equivalence. Understand the medazepam, phenazepam and add-on evidence.
Read article
Peptides7 min read
Why Selank dependence claims need longer follow-up
Short symptom reports cannot prove long-term freedom from dependence. Separate tolerance, physical dependence, addiction and symptoms after stopping.
Read article
Supplements9 min read
Ashwagandha stress studies: why a cortisol number is not the whole story
Ashwagandha trials show some short-term symptom benefits, but a lower morning cortisol value does not prove a hormonal reset or long-term safety.
Read article
Supplements9 min read
Paraxanthine versus caffeine: what the direct comparisons actually show
Direct caffeine comparisons now exist. Their small trials give different answers for cognitive tasks, rowing performance and subjective sleep.
Read article
Supplements9 min read
Oral glutathione: absorption and clinical benefit are different questions
Oral glutathione can change measured body compartments in some trials. Explore what formulation studies show—and why clinical benefits need separate evidence.
Read article
TRT9 min read
Clomiphene in Men: A Higher Testosterone Result Is Only Part of the Decision
Clomiphene can raise testosterone in selected men, but hormone response, symptom relief and fertility are separate outcomes. A useful plan defines all three and takes safety monitoring seriously.
Read article
TRT9 min read
Gonadorelin on TRT: Why Pulsatile Treatment Evidence Does Not Prove an Add-On Works
For gonadorelin, the delivery pattern is part of the treatment. Evidence from carefully selected patients using pulsatile therapy cannot simply be transferred to an occasional TRT add-on.
Read article
TRT9 min read
Injection frequency and the smooth-curve promise
A flatter testosterone curve can be useful, but it does not prove better symptoms or fewer harms. Frequency, total exposure and blood-test timing need separate attention.
Read article
TRT9 min read
Nasal testosterone and fertility: a small-study signal is not a guarantee
Small nasal-testosterone studies report encouraging sperm measurements, but selection, follow-up and surrogate endpoints limit what they establish about fertility.
Read article350–361 of 600 articles